MERTK and acute lymphoblastic leukemia: Importantly, shRNA-mediated inhibition of MERTK in T-ALL cell lines inhibited signaling through the JAK/STAT and MAPK pathways, increased chemosensitivity, and prolonged survival in mice with xenografts [14].